![](/img/cover-not-exists.png)
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
Jabbour, E., Kantarjian, H. M., Saglio, G., Steegmann, J. L., Shah, N. P., Boque, C., Chuah, C., Pavlovsky, C., Mayer, J., Cortes, J., Baccarani, M., Kim, D.-W., Bradley-Garelik, M. B., Mohamed, H., WVolume:
123
Language:
english
Journal:
Blood
DOI:
10.1182/blood-2013-06-511592
Date:
January, 2014
File:
PDF, 366 KB
english, 2014